Breast Neoplasms: all 12,820 studies
Page 84 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- EPR Tumor Oximetry With CE India InkTerminatedNCT03321903
- Hypofractionated Radiation Therapy With Concomitant Boost in Treating Women After Breast Conserving SurgeryCompletedNCT03320421Not applicable
- Thoracic Spinal Anesthesia in Awake Breast SurgeryCompletedNCT03319511Not applicable
- Kindness Interventions in Enhancing Well-Being in Breast Cancer SurvivorsCompletedNCT03319342Not applicable
- Post Mastectomy Hypofractionated Radiotherapy in High Risk Breast CancerStatus unknownNCT03319069Phase 3
- A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCCTerminatedNCT03318562Phase 2
- CIrCuLAting Dna ESr1 Gene Mutations AnalysisCompletedNCT03318263Not applicable
- A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC)TerminatedNCT03316794Phase 1
- Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line TherapyActive, not recruitingNCT03315364Phase 2/3
- Development of a Response Signature to Neoadjuvant Chemotherapy for Breast CancerStatus unknownNCT03314870Not applicable
- PG2 Breast Cancer Evaluation in Adjuvant Medicine StudyCompletedNCT03314805Phase 2
- Study Evaluating Hemay022 in Combination With Endocrine Therapy In Subjects With ER Positive and HER2 Positive Advanced Breast CancerCompletedNCT03308201Phase 1
- Fractional CO2 Laser Therapy for Survivors of Breast MalignanciesCompletedNCT03307044Not applicable
- A Pre-operative Window Study of Letrozole Plus PR Agonist (Megestrol Acetate) Versus Letrozole Alone in Post-menopausal Patients With ER-positive Breast CancerCompletedNCT03306472Phase 2
- Study of Neoadjuvant Treatment of Locally Advanced Breast Cancer With CAP RegimenCompletedNCT03304756Phase 2
- Overall Diet Quality and Breast Cancer RiskCompletedNCT03304171
- Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic BreastActive, not recruitingNCT03304080Phase 1/2
- Implementation of a Web-based Decision Aid for Breast Cancer SurgeryCompletedNCT03304002
- London Investigation Into diElectric Scanning of LesionsStatus unknownNCT03302819Not applicable
- Genomic Testing and Resulting Medical DecisionsCompletedNCT03301493
- Interhospital Variability in Programmes to Prevent Axillary Lymphadenectomy Sequels in Breast Cancer Patients.CompletedNCT03300349
- Early Detection of Cardiovascular Changes After Radiotherapy for Breast CancerCompletedNCT03297346Not applicable
- Evaluation of a 3D Functional Metabolic Imaging and Risk Assessment System in Classifying Women for Likelihood of Breast CancerStatus unknownNCT03296683Not applicable
- Stereotactic Body Radiotherapy for Patients With Breast Cancer OligometastasisStatus unknownNCT03295916Early Phase 1
- PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer PatientWithdrawnNCT03295695Early Phase 1
- Decitabine Plus Carboplatin in the Treatment of Metastatic TNBCTerminatedNCT03295552Phase 2
- Ribociclib + PDR001 in Breast Cancer and Ovarian CancerTerminatedNCT03294694Phase 1
- Merestinib on Bone Metastases in Subjects With Breast CancerTerminatedNCT03292536Phase 1
- Subclinical Lymphedema Treatment StudyActive, not recruitingNCT03292198Not applicable
- A Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RO6870810 and Atezolizumab (PD-L1 Antibody) in Participants With Advanced Ovarian Cancer or Triple Negative Breast CancerTerminatedNCT03292172Phase 1
- IACS-010759 in Advanced CancersCompletedNCT03291938Phase 1
- Phase 2 Study of KHK2375 in Subjects With Advanced or Recurrent Breast CancerCompletedNCT03291886Phase 2
- Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBCCompletedNCT03289819Phase 2
- Pilot Study Evaluating a Perioperative E-follow-up Protocol in Patients With Ambulatory Surgery for Breast CancerCompletedNCT03289286Not applicable
- Evaluate The Accuracy Of Breast MRI Biopsy In Diagnosing A Complete Tumor Response For Some Women Following Neoadjuvant Chemotherapy For Breast CancerActive, not recruitingNCT03289195Not applicable
- Comparison of Microwave Ablation With Cryoablation for Breast TumorStatus unknownNCT03286413Not applicable
- Can Exercise Training Reduce the Frequency and Severity of Hot Flushes Associated With Breast Cancer Treatment?CompletedNCT03286257Not applicable
- MCS110 Combined With Neoadjuvant Doxorubicin, Cyclophosphamide, and Weekly Paclitaxel in Patients With Hormone-Receptor Positive and HER2- Breast CancerWithdrawnNCT03285607Phase 1
- Patterns of Prescribing and Monitoring of PalbociclibCompletedNCT03285568
- CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast CancerActive, not recruitingNCT03285412Phase 2
- The French E3N Prospective Cohort StudyActive, not recruitingNCT03285230
- Kinetics of Perioperative Circulating DNA in Cancer SurgeryCompletedNCT03284684
- Football Fitness After Breast CancerCompletedNCT03284567Not applicable
- Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer SurvivorsTerminatedNCT03284346Not applicable
- Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.Active, not recruitingNCT03283384Phase 2
- Clinical Study of Decitabine and Paclitaxel Combination TherapyStatus unknownNCT03282825Phase 1
- Metabolomics and Breast Cancer Risk in a Nested Case-control Study of the Cancer Prevention Study-II Nutrition CohortCompletedNCT03282812
- A Self-Management Energy Conservation Program for Cancer-Related FatigueCompletedNCT03282214Phase 2
- Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine TherapyActive, not recruitingNCT03281902
- Clinical Study of ALT-P7 to Determine Safety, Tolerability and Pharmacokinetics in Breast Cancer PatientsCompletedNCT03281824Phase 1
- Whole Breast + Lymph Node Irradiation: Prone Compared to Supine Position in 15 or 5 FractionsCompletedNCT03280719Not applicable
- A Prospective Validation Cohort Study of a Prediction System on nSLN Metastasis in Early Breast CancerStatus unknownNCT03280134Not applicable
- Increasing Colorectal and Breast Cancer Screening in WomenCompletedNCT03279198Not applicable
- Aerobic Exercise and Cognitive Functioning in Women With Breast CancerStatus unknownNCT03277898Not applicable
- A Guided Internet-delivered Individually-tailored ACT-influenced CBT Intervention to Improve Psychosocial Outcomes in Breast CancerStatus unknownNCT03275727Phase 2/3
- Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive Breast CancerStatus unknownNCT03273595Phase 2
- Role of Oncoplastic Breast Surgery In Breast Cancer TreatementStatus unknownNCT03273348Not applicable
- Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer PatientsCompletedNCT03272477Phase 2
- Thermalogical Analysis of a Cohort of Women and Men Undergoing Mammographic Analysis.SuspendedNCT03271853
- EMDR Psychotherapy to Treat Anxious-depressive Symptoms in Breast Cancer PatientCompletedNCT03271476Not applicable
- Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT StudyCompletedNCT03270995Not applicable
- High Physical Activity During a Weight Loss Intervention for Breast Cancer Survivors and High Risk WomenCompletedNCT03270111Not applicable
- The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer PatientsActive, not recruitingNCT03270072
- Research of Intensive Treatment in Hormone Receptor<10% and Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer Patients With Positive Lymph Node Residual Disease After Neoadjuvant ChemotherapyStatus unknownNCT03270007Phase 4
- Randomized Study of Elective Regional Lymph Node Irradiation in N1 Breast CancerActive, not recruitingNCT03269981Not applicable
- CARdiac Function Evaluation in Breast Cancer PatientsCompletedNCT03266809
- Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone: A Whole Body MRI StudyStatus unknownNCT03266744Not applicable
- Estrogen Receptor Expression in Breast Cancer - Assessed With Positron Emission MammographyWithdrawnNCT03266562Not applicable
- PROACT: Can we Prevent Chemotherapy-related Heart Damage in Patients With Breast Cancer and Lymphoma?CompletedNCT03265574Phase 3
- A Study to Compare Eribulin Mesylate + Pertuzumab + Trastuzumab With Paclitaxel or Docetaxel + Pertuzumab + TrastuzumabCompletedNCT03264547Phase 3
- Mindful Movement in Women Receiving Adjuvant or Neoadjuvant Therapy for Breast CancerCompletedNCT03262831Not applicable
- Collaborative Self-Management Support in Chronic Conditions - Qualitative StudyCompletedNCT03262428
- Breast Reconstruction Following Breast Cancer in Very High Risk PatientsWithdrawnNCT03261323Not applicable
- Understanding Value in Metastatic Breast CancerCompletedNCT03257917
- Delphinus SoftVue Prospective Case Collection - ARM 1CompletedNCT03257839
- Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast CancerActive, not recruitingNCT03255577Not applicable
- Identification and Evaluation of Biomarkers of Resistance to Neoadjuvant Chemotherapy (IDEA SEIN)CompletedNCT03255486Not applicable
- A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)CompletedNCT03255070Phase 1
- Rehabilitation After Breast CancerCompletedNCT03254875Not applicable
- Study in Leptomeningeal Metastases of Breast CancerCompletedNCT03252912Not applicable
- Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE)Active, not recruitingNCT03252717Not applicable
- PD-1(Programmed Death-1) Antibody +GP as First Line Treatment for Triple Negative Breast Cancer(TNBC) PatientsStatus unknownNCT03251313Phase 1
- Hypnosis for Patients Treated With Adjuvant Chemotherapy for Breast Cancer(HYPNOVAL)CompletedNCT03250130Not applicable
- Assessing the Changes in Markers of Calcium Vitamin Metabolism of for Breast Cancer Adjuvant (CALCIOBS)CompletedNCT03249389Not applicable
- Neadjuvant Multi-agent Chemotherapy or Letrozole Plus Ribociclib in Luminal B/HER2-negative Breast Cancer.CompletedNCT03248427Phase 2
- Enhancing Shared Decision-Making in Metastatic Breast Cancer (Qualitative Study)CompletedNCT03248258
- Computed Tomography (CT) Reconstruction for Axillary Lymph Node StructureCompletedNCT03247478
- Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.Active, not recruitingNCT03246841Not applicable
- Fusion Protein rHSA/GCSFclinical Study on Breast Cancer PatientsCompletedNCT03246009Phase 1
- Halaven Patient Registry (Metastatic Breast Cancer, MBC)Status unknownNCT03245112
- Cytokine Profiles in Breast Cancer Patients Undergoing ChemotherapyCompletedNCT03244943Not applicable
- Evaluation of Epalrestat in Metastatic Triple-negative Breast CancerTerminatedNCT03244358Phase 2
- Performance of MammoAlert™, Point of Care System, for the Screening of Breast Cancer in Women 18 Years of Age or OlderStatus unknownNCT03243877
- Low-dose Apatinib Combined With Neoadjuvant Chemotherapy in the Treatment of Early Triple Negative Breast CancerCompletedNCT03243838Phase 2
- Stay on Track: A Study of Exercise Effects During RadiationCompletedNCT03243786Not applicable
- Sienna+MR Long-term UptakeCompletedNCT03243435
- An Initial Safety Study of Gedatolisib Plus PTK7-ADC for Metastatic Triple-negative Breast CancerCompletedNCT03243331Phase 1
- PemVin vs Vin in Previously Treated Metastatic Breast CancerCompletedNCT03242616Phase 2
- Biomarkers Investigation of Neoadjuvant Chemotherapy for Breast CancerStatus unknownNCT03242551Phase 2
- Understanding Male Breast Cancer: Salah Azaïz Cancer Institute ExperienceStatus unknownNCT03240510